Riociguat
Chemical compound
Ratings
0
Nobody has rated this yet. Be the first!
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.